Chiara Spadazzi

1.9k total citations
53 papers, 1.2k citations indexed

About

Chiara Spadazzi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chiara Spadazzi has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Chiara Spadazzi's work include Sarcoma Diagnosis and Treatment (17 papers), Cancer Cells and Metastasis (12 papers) and Bone health and treatments (9 papers). Chiara Spadazzi is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Cancer Cells and Metastasis (12 papers) and Bone health and treatments (9 papers). Chiara Spadazzi collaborates with scholars based in Italy, United States and Netherlands. Chiara Spadazzi's co-authors include Laura Mercatali, Toni Ibrahim, Chiara Liverani, Alessandro De Vita, Giacomo Miserocchi, Alberto Bongiovanni, Federica Recine, Dino Amadori, Federica Pieri and Nada Riva and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Scientific Reports.

In The Last Decade

Chiara Spadazzi

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Spadazzi Italy 22 612 424 363 224 177 53 1.2k
Giacomo Miserocchi Italy 21 504 0.8× 277 0.7× 349 1.0× 177 0.8× 141 0.8× 62 1.0k
Federica Recine Italy 19 657 1.1× 234 0.6× 441 1.2× 204 0.9× 66 0.4× 57 1.2k
Chun‐Ming Huang Taiwan 23 796 1.3× 485 1.1× 308 0.8× 171 0.8× 129 0.7× 58 1.7k
Kanako C. Hatanaka Japan 24 613 1.0× 564 1.3× 409 1.1× 400 1.8× 94 0.5× 143 2.0k
Koichi Yoshikawa Japan 14 518 0.8× 601 1.4× 499 1.4× 267 1.2× 163 0.9× 45 1.7k
Kamalesh K. Sankhala United States 21 797 1.3× 838 2.0× 694 1.9× 194 0.9× 88 0.5× 77 1.8k
Renê Gerhard Brazil 21 985 1.6× 615 1.5× 243 0.7× 365 1.6× 84 0.5× 41 1.8k
Alberto Pisacane Italy 21 624 1.0× 486 1.1× 157 0.4× 269 1.2× 68 0.4× 49 1.4k
Sergey Popov United Kingdom 20 316 0.5× 825 1.9× 202 0.6× 349 1.6× 104 0.6× 48 1.5k
Judy A. Tjoe United States 14 410 0.7× 211 0.5× 364 1.0× 215 1.0× 113 0.6× 35 1.0k

Countries citing papers authored by Chiara Spadazzi

Since Specialization
Citations

This map shows the geographic impact of Chiara Spadazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Spadazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Spadazzi more than expected).

Fields of papers citing papers by Chiara Spadazzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Spadazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Spadazzi. The network helps show where Chiara Spadazzi may publish in the future.

Co-authorship network of co-authors of Chiara Spadazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Spadazzi. A scholar is included among the top collaborators of Chiara Spadazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Spadazzi. Chiara Spadazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanni, Silvia, Angela Maria Cusano, Angela Maria Cusano, et al.. (2025). Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancer. Nanoscale. 17(15). 9436–9457. 6 indexed citations
2.
Vanni, Silvia, Valentina Fausti, Giacomo Miserocchi, et al.. (2024). Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors. Heliyon. 10(23). e40596–e40596. 2 indexed citations
3.
Vanni, Silvia, Valentina Fausti, Eugenio Fonzi, et al.. (2023). Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need. International Journal of Molecular Sciences. 24(8). 6926–6926. 17 indexed citations
4.
Miserocchi, Giacomo, Giovanni De Luca, Sebastiano Calpona, et al.. (2023). High-grade transformation of a polymorphous adenocarcinoma of the salivary gland: a case report and review of the literature. Frontiers in Oncology. 13. 1245043–1245043. 1 indexed citations
5.
Liverani, Chiara, Chiara Spadazzi, Toni Ibrahim, et al.. (2023). HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors. Frontiers in Endocrinology. 13. 1045038–1045038. 3 indexed citations
6.
Miserocchi, Giacomo, Chiara Spadazzi, Sebastiano Calpona, et al.. (2022). Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches. Journal of Personalized Medicine. 12(6). 854–854. 25 indexed citations
7.
Esposito, Mark, Fang Cao, Katelyn C. Cook, et al.. (2021). TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. Nature Cell Biology. 23(3). 257–267. 90 indexed citations
8.
Bongiovanni, Alberto, Chiara Liverani, Federica Recine, et al.. (2020). Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis. Frontiers in Oncology. 10. 414–414. 10 indexed citations
9.
Spadazzi, Chiara, Laura Mercatali, Mark Esposito, et al.. (2020). Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis. Bone. 144. 115775–115775. 12 indexed citations
10.
Bongiovanni, Alberto, Chiara Liverani, Flavia Foca, et al.. (2020). 1175P Temozolomide alone or combined with capecitabine for the treatment of metastatic neuroendocrine neoplasia: A “Real World” data analysis. Annals of Oncology. 31. S778–S778. 1 indexed citations
11.
Recine, Federica, Alberto Bongiovanni, Flavia Foca, et al.. (2019). BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center “Real-Life” Experience (BOHEME Study). Journal of Clinical Medicine. 8(11). 1894–1894. 4 indexed citations
12.
Esposito, Mark, Nandini Mondal, Todd M. Greco, et al.. (2019). Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nature Cell Biology. 21(5). 627–639. 179 indexed citations
13.
Spadazzi, Chiara, Federica Recine, Laura Mercatali, et al.. (2019). mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model. Journal of bone oncology. 16. 100227–100227. 7 indexed citations
14.
Liverani, Chiara, Alberto Bongiovanni, Laura Mercatali, et al.. (2018). Grading of Neuroendocrine Carcinomas: Correlation of 68Ga-PET/CT Scan with Tissue Biomarkers. Disease Markers. 2018. 1–8. 9 indexed citations
15.
Vita, Alessandro De, Federica Recine, Laura Mercatali, et al.. (2017). Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents. International Journal of Molecular Sciences. 18(12). 2662–2662. 28 indexed citations
16.
Recine, Federica, Alberto Bongiovanni, Roberto Casadei, et al.. (2017). Primary leiomyosarcoma of the bone. Medicine. 96(45). e8545–e8545. 15 indexed citations
17.
Vita, Alessandro De, Laura Mercatali, Federica Recine, et al.. (2016). Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas. OncoTargets and Therapy. Volume 9. 6233–6246. 65 indexed citations
18.
Vita, Alessandro De, Giacomo Miserocchi, Federica Recine, et al.. (2016). Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma. Molecules. 21(12). 1662–1662. 20 indexed citations
19.
Liverani, Chiara, Federico La Manna, Arwin Groenewoud, et al.. (2016). Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. Annals of Oncology. 27. iv117–iv117. 4 indexed citations
20.
Liverani, Chiara, Laura Mercatali, Chiara Spadazzi, et al.. (2014). CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems. Bone. 66. 214–222. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giacomo Miserocchi Breakdown of academic impact, for papers by Federica Recine Breakdown of academic impact, for papers by Chun‐Ming Huang Breakdown of academic impact, for papers by Kanako C. Hatanaka Breakdown of academic impact, for papers by Koichi Yoshikawa Breakdown of academic impact, for papers by Kamalesh K. Sankhala Breakdown of academic impact, for papers by Renê Gerhard Breakdown of academic impact, for papers by Alberto Pisacane Breakdown of academic impact, for papers by Sergey Popov Breakdown of academic impact, for papers by Judy A. Tjoe
Rankless by CCL
2026